Sleep-inducing effects mediated by a selective orexin-2 receptor antagonist during the light phase in the rat

被引:0
|
作者
Shelton, J. [1 ]
Sutton, S. [1 ]
Yun, S. [1 ]
Li, S. [1 ]
Dvorak, C. [1 ]
Carruthers, N. [1 ]
Lovenberg, T. [1 ]
Dugovic, C. [1 ]
机构
[1] Johnson & Johnson PRDUS LLC, San Diego, CA USA
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:201 / 201
页数:1
相关论文
共 50 条
  • [31] The selective orexin-2 antagonist seltorexant (JNJ-42847922/MIN-202) shows antidepressant and sleep-promoting effects in patients with major depressive disorder (vol 9, 216, 2019)
    Recourt, Kasper
    de Boer, Peter
    Zuiker, Rob
    Luthringer, Remy
    Kent, Justine
    van der Ark, Peter
    Van Hove, Ilse
    van Gerven, Joop
    Jacobs, Gabriel
    van Nueten, Luc
    Drevets, Wayne
    TRANSLATIONAL PSYCHIATRY, 2019, 9 (1)
  • [32] COMPARISON OF THE EFFECTS OF 2 SLEEP PEPTIDES, DELTA SLEEP-INDUCING PEPTIDE AND ARGININE-VASOTOCIN, ON SINGLE NEURONS IN THE RAT AND RABBIT BRAIN-STEM
    NORMANTON, JR
    GENT, JP
    NEUROSCIENCE, 1983, 8 (01) : 107 - 114
  • [33] JNJ-42847922/MIN-202, a selective orexin 2 receptor antagonist, demonstrates beneficial effects on mood and sleep in patients with major depressive disorder
    Recourt, K.
    Van Amerongen, G.
    Jacobs, G.
    Zuiker, R.
    Luthringer, R.
    Van der Ark, P.
    Van Gerven, J.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2017, 27 : S866 - S866
  • [34] The Dual Orexin Receptor Antagonist DORA-22 Improves Mild Stress-induced Sleep Disruption During the Natural Sleep Phase of Nocturnal Rats
    Gamble, Mackenzie C.
    Katsuki, Fumi
    McCoy, John G.
    Strecker, Robert E.
    McKenna, James T.
    NEUROSCIENCE, 2021, 463 : 30 - 44
  • [35] Effects of a non-selective muscarinic receptor antagonist, scopolamine, on REM sleep quantified EEG activity in the rat
    Ruiz, OD
    Beaulieu, I
    Godbout, R
    SLEEP, 2001, 24 : A152 - A153
  • [36] Effects of selective dopamine D4 receptor antagonist, L-741,741, on sleep and wakefulness in the rat
    Cavas, Maria
    Navarro, Jose Francisco
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2006, 30 (04): : 668 - 678
  • [37] Opposite effects of sleep rebound on orexin OX1 and OX2 receptor expression in rat brain
    D'Almeida, V
    Hipólide, DC
    Raymond, R
    Barlow, KBL
    Parkes, JH
    Pedrazzoli, M
    Tufik, S
    Nobrega, JN
    MOLECULAR BRAIN RESEARCH, 2005, 136 (1-2): : 148 - 157
  • [38] Effects of TS-142, a novel dual orexin receptor antagonist, on sleep in patients with insomnia: a randomized, double-blind, placebo-controlled phase 2 study
    Makoto Uchiyama
    Daiji Kambe
    Yumiko Imadera
    Yu Kajiyama
    Hiroki Ogo
    Naohisa Uchimura
    Psychopharmacology, 2022, 239 : 2143 - 2154
  • [39] Effects of TS-142, a novel dual orexin receptor antagonist, on sleep in patients with insomnia: a randomized, double-blind, placebo-controlled phase 2 study
    Uchiyama, Makoto
    Kambe, Daiji
    Imadera, Yumiko
    Kajiyama, Yu
    Ogo, Hiroki
    Uchimura, Naohisa
    PSYCHOPHARMACOLOGY, 2022, 239 (07) : 2143 - 2154
  • [40] EFFECTS OF THE SELECTIVE DOPAMINE D-2 RECEPTOR AGONIST, QUINPIROLE ON SLEEP AND WAKEFULNESS IN THE RAT
    MONTI, JM
    JANTOS, H
    FERNANDEZ, M
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1989, 169 (01) : 61 - 66